Navellier & Associates’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-20,760	Closed	-$1.75M	–	292
2019 Q2	$1.75M	Sell	20,760 -4	-0%	-$338	0.27%	98
2019 Q1	$1.83M	Buy	20,764 +757	+4%	+$66.7K	0.28%	92
2018 Q4	$1.43M	Sell	20,007 -11,387	-36%	-$813K	0.24%	89
2018 Q3	$3.86M	Buy	+31,394	New	+$3.86M	0.5%	58